Dissertations / Theses on the topic 'Biological Mechanism of Action'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Biological Mechanism of Action.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Deans, Bryan. "Studies on the mechanism of action on antitumour imidazotetrazinones." Thesis, Aston University, 1994. http://publications.aston.ac.uk/11048/.
Full textMungthin, Mathirut. "Studies on the mechanism of action and mechanism of resistance to quinoline-containing antimalarial drugs in Plasmodium falciparum." Thesis, University of Liverpool, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.263874.
Full textSanders, Paul Michael. "Mechanism of action of a tumour derived lipid mobilising factor." Thesis, Aston University, 2003. http://publications.aston.ac.uk/11005/.
Full textMatkar, Smita S. "Mechanism of action of potential anticancer drugs." Scholarly Commons, 2008. https://scholarlycommons.pacific.edu/uop_etds/2368.
Full textDuan, Xuchen. "Physiological and biological mechanisms of bisphosphonate action." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:36b0439d-2f89-4c1e-8bb3-941b4e6ee847.
Full textMoreno, González M. del Carmen. "Characterization and mechanism of action of the biological control agent Pantoea agglomerans EPS125." Doctoral thesis, Universitat de Girona, 2006. http://hdl.handle.net/10803/7796.
Full textD'acord amb els resultats obtinguts mitjançant proves fenotípiques i genotípiques, la soca EPS125 queda inclosa dins l'espècie Pantoea agglomerans (Enterobacter agglomerans-Erwinia herbicola). En relació a la utilització de fonts de carboni, en el perfil i contingut d'àcids grassos cel·lulars i en el polimorfisme en la longitud dels fragments de macrorestricció genòmica (MRFLP), la soca EPS125 mostrà trets característics que la diferencien d'altres soques. Els dos marcadors moleculars (125.2 i 125.3) específics per la soca EPS125 dissenyats en el present treball mostraren ser semiespecífics per la seva detecció mitjançant la tècnica PCR i Real Time PCR. Quedant pendent l'anàlisi d'especificitat de l'ús combinat dels dos marcadors moleculars en una reacció PCR multiplex. P. agglomerans EPS125 ha mostrat ser molt efectiva en el control de Penicillium expansum en poma amb una dosi efectiva mitjana de 2.7x105 a 7x105 ufc/ml, i una ratio de 25-101 cèl·lules de la soca EPS125 per inactivar una espora del patogen segons el model de saturació hiperbòlica. Segons les aproximacions fenotípiques i estudis genotípics realitzats, sembla que els mecanismes de biocontrol utilitzats per la soca EPS125 contra P. expansum en poma estan directament relacionats amb la capacitat de formació de biofilm per aquesta soca.
Strain EPS125 has shown effectiveness against a wide range of fungal pathogens in a large variety of fruit. However, to develop this strain as commercial biopesticide an extensive characterization is essential. For this reason, the objective of this PhD thesis was to complete the necessary information for its future registration.
According to morphological and biochemical tests, strain EPS125 pertain to Pantoea agglomerans (Enterobacter agglomerans-Erwinia herbicola) species. This strain showed typical traits different from other bacteria in relation to the ability to use several carbon sources, the fatty acid profiles and the macrorestriction fragment length polymorphism (MRFLP) pattern. The two DNA molecular markers of P. agglomerans EPS125 (125.2 and 125.3) obtained in the present work were semispecific in the detection of strain EPS125 by means of PCR and Real Time PCR. However, the combined use of the two primer sets in a multiplex PCR reaction would be specific. P. agglomerans EPS125 was highly effective against P. expansum in apple fruit having a median effective dose from 2.7x105 to 7x105 cfu/ml and a ratio of 101 and 25 EPS125 cells to inactivate one pathogen spore according to the hyperbolic saturation model.
Biocontrol mechanisms used by P. agglomerans EPS125 against P. expansum in apple fruit may be related with the ability of biofilm formation by this strain as show phenotypic approaches and genotypic studies.
Tatarski, Miloš. "Molecular mechanism of dBigH1 action." Doctoral thesis, Universitat de Barcelona, 2018. http://hdl.handle.net/10803/663021.
Full textMuraro, Lucia. "Studies of Botulinum Neurotoxins Mechanism of Action." Doctoral thesis, Università degli studi di Padova, 2009. http://hdl.handle.net/11577/3425607.
Full textAshraf, Sadia. "Study of mechanism of action of Scorpion neurotoxins." Doctoral thesis, Università degli studi di Padova, 2013. http://hdl.handle.net/11577/3423586.
Full textRIASSUNTO Gli Scorpioni sono importanti rappresentanti del phylum Artropodi. Essi si sono ben adattati a condizioni ambientali estreme e giocano un ruolo fondamentale in diversi ecosistemi. Allo stesso tempo gli scorpioni sono responsabili di più di 1.2 milioni di punture per anno con quasi 3000 morti in tutto il mondo. Sono due le famiglie di scorpioni pericolose per l’uomo: Buthida e Hemiscorpiidae. Le punture di scorpione possono causare da effetti lievi come rossore, e dolore a effetti gravi che causano danni a diversi organi ed eventualmente la morte del soggetto colpito. Il veleno di scorpione è costituito da diversi componenti come peptidi a basso peso molecolare, lipidi ed enzimi. Gli effetti patologici della puntura di scorpione sono causati dalla presenza di diverse tossine (neurotossina, cardiotossina, nefrotossina, tossina emolitica) e diversi enzimi (fosfodiesterasi, fosfolipasi, ialuronidasi) nel veleno. Dato che gli scorpioni hanno una lunga storia evolutiva, durante questo lungo periodo hanno sviluppato un serie di peptidi e proteine che possiedono diverse funzioni biologiche. Grazie alla loro abbondanza e quindi alla facilità d’isolamento, i componenti del veleno più studiati sono le tossine che esplicano la loro azione sui canali ionici i quali sono stati molto studiati e descritti in dettaglio in letteratura. Recentemente è stata descritta una nuova classe di metalloproteasi di scorpione capace di proteolizzare le proteine SNARE che è stata denominata Antarease. Fino ad ora le proteine SNARE che hanno un ruolo chiave nel processo di neuroesocitosi, sono state descritte essere il bersaglio molecolare solo di neurotossine batteriche quali le tossine del tetano e del botulismo. Per studiare questa nuova classe di metalloproteasi, abbiamo analizzato l’azione di diversi veleni di scorpioni sia su proteine SNARE ricombinanti sia su modelli di neuroni primari in coltura. Questo studio ha dimostrato la presenza di metalloproteasi simili all’Antarease in specie di scorpioni Buthus eupeus e Orthochirus scrobiculosus e che questi enzimi sono in grado di proteolizzare in maniera specifica le proteine SNARE.
LIPARI, Elisa. "DEVELOPMENT AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DEAMIDATED IFNβ-1a AND INVESTIGATION ABOUT THE MECHANISM OF ACTION." Doctoral thesis, Università degli Studi di Palermo, 2021. http://hdl.handle.net/10447/497430.
Full textBurman, Jonas. "Mechanisms of action of β-blockers for the treatment of heart failure." Thesis, Linköpings universitet, Biologi, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-167006.
Full textJagatia, Heena. "The biological role and mechanism of action of rbpA and carD in Streptomyces coelicolor A3 (2) and Mycobacterium tuberculosis." Thesis, University of Sussex, 2018. http://sro.sussex.ac.uk/id/eprint/80557/.
Full textSalazar, Montoya Vivian Angélica. "Exploring the mechanism of action of human antimicrobial ribonucleases." Doctoral thesis, Universitat Autònoma de Barcelona, 2015. http://hdl.handle.net/10803/310611.
Full textHuman ribonucleases are a heterogeneous group of proteins belonging to the superfamily of RNase A. These proteins are characterized by their ability to hydrolyse ribonucleic acids and the presence of antimicrobial activity against various pathogens including bacteria, fungi, parasites and viruses. The first objective of this doctoral study is focused on the antimicrobial characterization of native Ribonuclease 3 forms purified from eosinophils. Native forms present posttranslational modifications giving different glycosylation grades that modulate their activity during inflammatory processes. This study aims to establish the antimicrobial properties of native forms purified from eosinophils and their activity in a membrane model system. Results indicate that post-translational modifications contribute to the the protein biological activities, suggesting a related physiological role. As a second objective, we evaluated for the first time the antifungal activity of the antimicrobial RNase 3 and RNase 7 against Candida albicans, an eukaryotic pathogen selected as a simple model to test the antimicrobial mechanism of action. Both human ribonucleases displayed a high antifungal activity. Results highlighted a dual mechanism of action, where cell lysis takes place at high protein concentration, while depolarization, cell internalization and cellular RNA degradation is achieved at sublethal doses. Finally, the last objective is focused on the characterization of ribonuclease 8, also called the placental RNase, the most recent human ribonuclease described. RNase 8 has gained and lost one cysteine residue in non-conserved positions in a mechanism called "disulphide shuffling". The protein tendency to aggregate required the design of an alternative purification protocol. We analysed its antimicrobial abilities, suggesting a possible role in innate defence. The results of this study confirmed the high antimicrobial activity of several human ribonucleases from the RNase A superfamily suggesting an ancestral role in the host immune defence response. The study contributed to the understanding of their mechanism of action and set the basis for applied drug design.
Chandranath, Swaminathan Irwin. "Comparitive activities and mechanisms of action of three novel antiulcer agents." Thesis, University of Central Lancashire, 2000. http://clok.uclan.ac.uk/21028/.
Full textKodack, David Philip. "Signaling of the pleiotrophin growth factor through the anaplastic lymphoma kinase receptor studies on mechanism of action, biological activity and inhibitors /." Connect to Electronic Thesis (CONTENTdm), 2009. http://worldcat.org/oclc/457188845/viewonline.
Full textJaksevicius, Andrius. "Elucidation of mechanisms by which culinary herbs and spices exert their inhibitory action on the growth of CRC cells in vitro." Thesis, Kingston University, 2017. http://eprints.kingston.ac.uk/41153/.
Full textLópez, Antón Nancy. "Identification of novel mechanisms of action contributing to the biological activity of cytotoxic natural compounds." Diss., lmu, 2006. http://nbn-resolving.de/urn:nbn:de:bvb:19-53326.
Full textRawls, Eric L. "Neural Mechanisms of Action Switching Moderate the Relationship Between Effortful Control and Aggression." ScholarWorks@UNO, 2016. http://scholarworks.uno.edu/td/2234.
Full textLAZZATI, ZELDA. "Speciation of particulate matter's organic fraction and its mechanis of action on human health." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2009. http://hdl.handle.net/10281/7466.
Full textTeixeira, Lúcia de Fátima Moreira. "Role and mechanism of action of human immunoregulatory iNKT cells in Leishmania infection: new approaches for vaccination?" Doctoral thesis, Faculdade de Farmácia da Universidade do Porto, 2010. http://hdl.handle.net/10216/63808.
Full textTeixeira, Lúcia de Fátima Moreira. "Role and mechanism of action of human immunoregulatory iNKT cells in Leishmania infection: new approaches for vaccination?" Tese, Faculdade de Farmácia da Universidade do Porto, 2010. http://hdl.handle.net/10216/63808.
Full textMohaibes, Raheem J. "Efficacy and mechanism of action of novel synthetic fatty acids derivatives in a transgenic Drosophila melanogaster Model of a Alzheimer's disease." Doctoral thesis, Universitat de les Illes Balears, 2015. http://hdl.handle.net/10803/378038.
Full text- Introducció La enfermedad de Alzheimer (AD, del inglés Alzheimer's disease) es una patología neurodegenerativa caracterizada por una pérdida temprana de conexiones sinápticas y, de manera tardía, de neuronas. Esta enfermedad afecta a unos 40 millones de personas en todo el mundo. Entre las personas con demencia, más de la mitad sufren AD. El mayor riesgo para desarrollar la enfermedad de Alzheimer es la edad. De hecho, las placas β-amiloide (Aβ) y ovillos neurofibrilares de fosfo-Tau se acumulan en los cerebros de pacientes ancianos, jugando un papel central en la patogénesis de AD. Además, se han encontrado reducciones significativas en los niveles de los lípidos fosfatidiletanolamina y ácido docosahexaenoico (DHA) en el cerebro de pacientes con AD. Durante la última década, la mosca de la fruta (Drosophila melanogaster) se ha utilizado como modelo para enfermedades neurodegenerativas, debido a que puede ser utilizada para el análisis de conductas como el aprendizaje aversivo y apetitivo, así como su capacidad de utilizar la información aprendida de previas experiencias, aunque la mosca adulta presenta un sistema nervioso mucho más simple que el de vertebrados. - Contingut de la investigació La presente investigación se centra en la utilización de Drosophila como modelo de AD mediante la sobreexpresión de los genes humanos asociados con AD (Aβ42 y Tau) en el sistema nervioso central de la mosca. El principal objetivo de desarrollar este modelo es analizar y estudiar el efecto de ácidos grasos sintéticos novedosos en la terapia de la AD. Conjuntamente, los organismos modelo establecidos en este trabajo pueden constituir un sistema que permita la comprensión de los procesos específicos de la enfermedad que desencadena la pérdida neuronal. Con todo ello, el presente trabajo demuestra que se puede usar Drosophila para estudiar las bases comportamentales de las enfermedades humanas neurodegenerativas y puede suponer un modelo para identificar nuevas terapias para dichas enfermedades, tales como AD. Además, se ha estudiado el efecto de la terapia lipídica de membrana en el declive cognitivo del modelo transgénico de AD de Drosophila. - Conclusió Los tratamientos empleados se basan en el uso de DHA y su derivado hidroxilado OHDHA, ARA y su forma hidroxilada OHARA y EPA y su forma hidroxilada OHEPA, así como derivados de triacilgliceroles (triacilglicerol miméticos, TGM) a dosis crecientes y añadidos en la comida. Tras confirmar la expresión de los transgenes en la generación F1 de las moscas por PCR y western blot, se analizó la toxicidad de los distintos compuestos y se demostró que la suplementación de comida con OHDHA, OHARA, OHEPA restauró la pérdida de actividad locomotora, parcialmente, además, aumentó la vida media de las moscas expresando los transgenes humanos, mientras que DHA, ARA, EPA no presentaron efectos significativos. Se observó que las concentraciones de 30 y 100 μg/ml de las formas hidroxiladas, incluyendo las mezclas de (OHDHA+OHARA), (OHEPA+OHARA) y 30 μg/ml de TGMs, LP183A1, LP183A2, mejoraron la capacidad cognitiva y aumentaron la vida media con respecto al grupo control no tratado. También se analizó el contenido lipídico en membranas de la cabeza de moscas mediante cromatografía de gases y se observó que la suplementación de la comida, tanto con los compuestos hidroxilados como los no-hidroxilados estudiados, indujo cambios en el perfil de ácidos grasos de Drosophila melanogaster. Entre ellos, se observó una menor cantidad de ácidos grasos de cadena corta en cabezas de moscas F1 tratadas con ARA, EPA and DHA en comparación con moscas no tratadas. En cuanto a los ácidos grasos hidroxilados, presentaron un nivel similar en la reducción de los niveles de ácidos grasos de cadena corta. Además, todos los suplementos añadidos a la comida indujeron un aumento de los ácidos grasos de cadena larga (≥ 18C). Finalmente, se observó la presencia de ARA, EPA y DHA en el perfil de ácidos grasos de las moscas tratadas con el correspondiente ácido graso no-hidroxilado. Este hecho prueba la absorción e incorporación de los ácidos grasos poliinsaturados presentes en la dieta en los tejidos de la Drosophila.
Raitano, Arthur Bartholomew. "Reciprocal modulation of tumor necrosis factor and gamma interferon receptors in human carcinoma cells: Biological significance and mechanisms of action." Diss., The University of Arizona, 1991. http://hdl.handle.net/10150/185483.
Full textCabrefiga, Olamendi Jordi. "Fire blight (Erwinia amylovora) of rosaceous plants. Pathogen virulence and selection and characterization of biological control agents." Doctoral thesis, Universitat de Girona, 2004. http://hdl.handle.net/10803/7924.
Full textFire blight, caused by Erwinia amylovora is a serious disease of rosaceous plants with great commercial and economic interest that is distributed over the world. Disease may be controlled commercially by the application of chemicals (copper compounds, antibiotics). Many chemical agents have low activity or cause phytotoxicity, and streptomycin, the most effective antibiotic, is not approved for use in many countries, including Spain. Therefore, in the absence of suitable chemical control agents, biological control could provide a useful alternative. In the present work, a biological control agent, Pseudomonas fluorescens EPS62e, has been selected among 600 isolates of P. fluorescens and Pantoea agglomerans obtained from flowers, fruits and leaves of rosaceous plants in a survey performed through several geographic areas of Spain. This strain has been selected for its capacity to suppress immature fruit, blossom and shoot infections caused by E. amylovora, under controlled environment conditions, providing control levels similar to chemical control with copper or antibiotic compounds. The strain has also shown the capacity to colonize and survive well in flowers and wounds on immature fruit under controlled environment conditions but also in flowers under natural conditions. Pre-emptive exclusion of the pathogen E. amylovora by surface colonization and nutrients depletion, and cell-to-cell interaction appear to be the main mechanisms of biocontrol. These characteristics constitute interesting traits for an effective development as a fire blight biological control agent under commercial conditions.
Zemaryalai, Khatera. "Investigations into the roles of potassium channels in hair growth : studies confirming the presence of several ATP-sensitive potassium (K+ATP) channels in hair follicles and exploring their mechanism of action using molecular biological, cell culture, organ culture and proteomic approaches." Thesis, University of Bradford, 2010. http://hdl.handle.net/10454/4461.
Full textMartis, Prithy Caroline. "RENCA macrobeads inhibit tumor cell growth via EGFR activation and regulation of MEF2 isoform expression." Wright State University / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=wright1597229612949836.
Full textSalvadori, Mirian Graciela da Silva Stiebbe. "Mecanismo de ação da atividade antinociceptiva e anti-inflamatória do (-) - mirtenol." Universidade Federal da Paraíba, 2013. http://tede.biblioteca.ufpb.br:8080/handle/tede/6810.
Full textCoordenação de Aperfeiçoamento de Pessoal de Nível Superior
The essential oils of herbs have a variety of bioactive compounds, such as monoterpenes. These monoterpenes have several pharmacological activities described as analgesic, anti-inflammatory, antidepressant and anticonvulsant, among others. The (-)- myrtenol is a monoterpene alcohol monocyclic, of pleasant odor, used in the cosmetics industry. However, the absence of research on possible pharmacological activities of this monoterpene has encouraged the present research. This study investigates the effect of (-)- myrtenol, intraperitoneally in adult male Swiss mice under experimental models of pain and inflammation. Initially, the research was initiated with lethal dose 50 (LD50) of monoterpene, in order to establish safe doses for subsequent tests. To investigate the action profile of monoterpene in the central nervous system, a pharmacological screening behavior was carried out, the effect of which in animals treated with (-)- myrtenol was that of analgesia. Then methodologies were conducted to evaluate the antinociceptive activity. The (-)- myrtenol (25, 50 and 100 mg/kg, i.p) increased the latency to the onset of abdominal writhing induced by acetic acid and reduced the number of writhing when compared to the control group. In the formalin test, using the same doses, (-) myrtenol did not alter the duration of paw licking in the neurogenic phase (0-5 min), but it inhibited significantly (p <0,001) the time of paw licking along the inflammatory phase (15-30 min). In the test of nociception induced by glutamate, the three doses of monoterpene reduced time of paw licking. In the hot plate test, which is sensitive and specific to drugs that act through a central mechanism, the (-)- myrtenol did not alter the paw withdrawal latency. With these results, we propose that the antinociceptive action of (-)- myrtenol may be a peripheral and not central mechanism of action. In an attempt to elucidate the mechanism of action involved in the antinociceptive effect of (-)- myrtenol, pharmacological tools were used in the formalin test. The antinociception produced by (-)- myrtenol (100 mg/kg, i.p) was reversed by naloxone (5 mg/kg, s.c) naloxonazine (10 mg/kg, s.c), glibenclamide (10 mg/kg, s.c), L-NOARG (50mg/kg, i.p) and yohimbine (0,15 mg/kg, i.p) only in the second phase of the formalin test. In view of the outstanding action of monoterpene in the second phase of the formalin test, we have investigated its possible anti-inflammatory activity. In this evaluation, treatment with (-)- myrtenol (50 and 100 mg/kg, i.p) was effective in reducing the paw edema induced by carrageenan (500 mg / paw), prostaglandin E2 (5 nmol / paw) and bradykinin (3 nmol / paw) at all times tested. In the model of carrageenan-induced peritonitis (1%), the monoterpene decreased the influx of leukocytes and also the levels of IL-1β and TNF-α in peritoneal fluid. Therefore, this study has demonstrated that (-)- myrtenol has antinociceptive activity with the participation of opioid receptor μ1, K+ATP channels, oxidonitrergic and adrenergic α2. Furthermore, (-)- myrtenol has exhibited anti-inflammatory activity by inhibiting the formation of paw edema and reduced leukocyte influx, possibly by inhibiting the production of pro-inflammatory cytokines IL-1β and TNF-α.
Os óleos essenciais obtidos de plantas medicinais possuem uma variedade de compostos bioativos, como os monoterpenos. Estes monoterpenos possuem distintas atividades farmacológicas descritas, como analgésica, anti-inflamatória, antidepressiva e anticonvulsivante dentre outras. O (-)-mirtenol é um monoterpeno, álcool monocíclico, de odor agradável, utilizado na indústria de cosméticos. No entanto, a ausência de pesquisas sobre as possíveis atividades farmacológicas deste monoterpeno incentivou à realização deste trabalho. O presente estudo investigou o efeito do (-)- mirtenol, pela via intraperitoneal, em camundongos suíços machos adultos em modelos experimentais de dor e de inflamação. Inicialmente, foi realizada a pesquisa da dose letal 50 (DL50) do monoterpeno, no intuito de estabelecer doses seguras para os testes subsequentes. Para investigar o perfil de ação do monoterpeno no sistema nervoso central foi realizado a triagem farmacológica comportamental e o principal efeito observado nos animais tratados com (-)- mirtenol foi analgesia. Em seguida, foram realizadas metodologias para avaliar a atividade antinociceptiva. O (-)- mirtenol (25, 50 e 100 mg/kg, i.p.) aumentou a latência para o inicio das contorções abdominais induzidas por ácido acético e reduziu o número de contorções, quando comparado ao grupo controle. No teste da formalina, utilizando as mesmas doses, o (-) - mirtenol não alterou o tempo de lambida da pata na fase neurogênica (0-5 min), mas inibiu significativamente (p<0,001) o tempo de lambida da pata na fase inflamatória (15-30 min). No teste da nocicepção induzida por glutamato, as três doses do monoterpeno reduziram o tempo de lambida da pata. Já no teste da placa quente, que é sensível e específico para drogas que atuam por mecanismo central, o (-)- mirtenol não alterou a latência na retirada da pata. Com estes resultados podemos propor que a ação antinociceptiva do (-)- mirtenol pode ser por mecanismo de ação periférica e não central. Na tentativa de elucidar o mecanismo de ação envolvido no efeito antinociceptivo do (-)- mirtenol foram usadas ferramentas farmacológicas no teste da formalina. A antinocicepção produzida pelo (-)- mirtenol (100 mg/kg i.p.) foi revertida pela naloxona (5 mg/kg s.c.), naloxonazine (10 mg/kg s.c.), glibenclamida (10 mg/kg s.c.), L-NOARG (50mg/kg i.p.) e ioimbina (0,15 mg/kg i.p) somente na segunda fase do teste da formalina. Tendo em vista a destacada ação do monoterpeno na segunda fase do teste da formalina, investigamos sua possível atividade anti-inflamatória. Nessa avaliação, o tratamento com o (-)- mirtenol (50 e 100 mg/kg, i.p.) foi capaz de reduzir o edema de pata induzido por carragenina (500 μg/pata), prostaglandina E2 (5 nmol/pata) e bradicinina (3 nmol/pata) em todos os tempos testados. No modelo da peritonite induzida por carragenina (1%), o monoterpeno diminuiu o influxo de leucócitos e também os níveis das citocinas IL-1β e TNF-α no lavado peritoneal. Portanto, este trabalho demonstrou que o (-)- mirtenol possui atividade antinoceptiva com participação dos sistemas opióidérgico μ1, canais de K+ATP, óxidonitrérgico e α2-adrenérgico. Além disso, possui atividade anti-inflamatória ao inibir a formação do edema de pata e reduzir o influxo de leucócitos possivelmente pela inibição da produção das citocinas pró-inflamatórias IL-1β e TNF-α.
Murakami, Mario Tyago. "Estratégias de inibição, mecanismos moleculares e interações intermoleculares em complexos macromoleculares /." São José do Rio Preto : [s.n.], 2006. http://hdl.handle.net/11449/100483.
Full textBanca: Antônio Carlos Martins Camargo
Banca: Nilson Ivo Tonin Zanchin
Banca: Beatriz Gómez Guimarães
Banca: Roberto da Silva
Abstract: This work presents some features of essential biological processes such as the haemostatic system, integrity of biological membranes and thermostability of proteins. Crystallographic, spectroscopic and in silico tools have been used to obtain information at the molecular level of macromolecular complexes, action mechanisms and inhibition pathways. Worms, snakes, ticks, leeches and spiders produce a variety of proteins, which interfere in the regulation of these systems. Different toxins isolated from these organisms were characterized providing necessary information for the development of a new anti-myonecrotic molecule and reveal a new factor Xa exosite that is important for macromolecular substrates recognition and inhibition. The first crystal structure of a member of the sphingomyelinases D family was determined by the "quick cryo-soaking" technique and the catalytic mechanism was proposed, which involves a magnesium-binding site and two catalytic histidines. An alternative activation of the protein C pathway that does not require thrombomodulin was structurally characterized and revealed the dual role of the elestrotatic surface charge around the active site and the three strategically positioned carbohydrate moieties in the approach, recognition and activation of protein C.
Doutor
Pham, Huy Dien. "Effets de differents anti-inflammatoires sur la migration et le metabolisme oxydatif des polynucleaires neutrophiles de rat." Paris 6, 1987. http://www.theses.fr/1987PA066194.
Full textGao, Hui. "Extracting key features for analysis and recognition in computer vision." Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1141770523.
Full textRuiz, Carmona Sergio. "Virtual screening for novel mechanisms of action: applications and methodological developments." Doctoral thesis, Universitat de Barcelona, 2017. http://hdl.handle.net/10803/400297.
Full textLa motivación principal de esta tesis ha sido validar, mejorar y desarrollar nuevos métodos con relación a los disponibles hoy en día en el área del desarrollo de fármacos, para en un futuro poder estudiar dianas que actualmente están fuera de nuestro alcance. Debido a que la productividad de la industria farmacéutica está disminuyendo durante los últimos años, una mejora en los métodos disponibles sería un gran paso adelante. Esta tesis se ha centrado en diferentes métodos computacionales, como el docking o la dinámica molecular. En la primera de las partes, trabajé en el cribado virtual (Virtual Screening) basado en docking. Concretamente, participé en la validación del programa de docking rDock mediante la comparación con dos programas muy usados hoy en día de su capacidad de predecir correctamente el modo de unión de un ligando con su proteína diana y de sus resultados en el cribado virtual de posibles fármacos. En la segunda parte de la tesis, participé en el desarrollo de un método computacional novedoso en el diseño de fármacos que complementase y mejorase los métodos actualmente disponibles. Éste método, bautizado en inglés como “Dynamic Undocking”, consiste en una implementación específica de dinámica molecular mediante la cual somos capaces de detectar si un ligando puede ser activo o inactivo de manera rápida y eficiente. Se validó el método de manera retrospectiva y posteriormente se aplicó en otro proyecto con el objetivo de encontrar nuevos posibles fármacos para una proteína relacionada con cáncer. Gracias a una colaboración con una empresa del Reino Unido, encontramos nuevos ligandos de manera que aumentamos la tasa de éxito con relación a un método estándar en casi 10 veces. Por último, participé en el “D3R Grand Challenge 2015”, un experimento a escala mundial donde los participantes aplicaron diferentes métodos y compararon sus resultados respecto a dos métricas distintas: la predicción del modo de unión y la capacidad de ordenar los ligandos proporcionados por la organización por su afinidad respecto a la proteína diana. En nuestro caso, aplicamos una combinación de docking y “Dynamic Undocking” con unos resultados excelentes.
Attarzadeh, Yazdi Ghassem. "Molecular mechanism of glucocorticoid action." Thesis, University of Edinburgh, 2006. http://hdl.handle.net/1842/26161.
Full textConti, Lucio. "The molecular mechanism of TFL1 action." Thesis, University of East Anglia, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.423575.
Full textBeastall, J. C. "The mechanism of action of azone." Thesis, University of Nottingham, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.380112.
Full textWilliams, Daffydd Griffin. "Mechanism of action of penetration enhancers." Thesis, Cardiff University, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.320625.
Full textTaylor, Catherine. "A mechanism of action of strigolactone." Thesis, University of Cambridge, 2015. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.709140.
Full textTaylor, M. R. G. "Mechanism of action of Rad51 paralogs." Thesis, University College London (University of London), 2015. http://discovery.ucl.ac.uk/1458671/.
Full textPhisit, Prapunwattana Yongyuth Yuthavong. "Mechanism of antimalarial action of tetracycline /." abstract, 1986. http://mulinet3.li.mahidol.ac.th/thesis/2529/29E-Phisit-P.pdf.
Full textJeganathan, Karthik Babu. "The mitotic checkpoint: mechanism and biological relevance." [S.l. : Groningen : s.n. ; University Library Groningen] [Host], 2008. http://irs.ub.rug.nl/ppn/.
Full textClark, Alice Rosemary. "The filamin A actin binding domain structure and function: implications for a gain-of-function mechanism for the otopalatodigital syndrome: a thesis presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biochemistry at Massey University, Palmerston North, New Zealand [Ph. D] EMBARGOED." Massey University, 2010. http://hdl.handle.net/10179/1185.
Full textThe filamin family act as scaffolding proteins associating with actin filmanents, acting through a highly conserved actin binding domain (ABD). The ABD of the filamins is homologous to that found in other F-actin binding proteins such as dystrophin. Mutations in the filamin A gene cause a wide range of disease symptoms in humans reflecting the diversity of the roles that filamin A has in cell structure and signalling pathways. The diseases fall into two separate phenotypic groups. Periventricular nodular heterotopia (PVNH) generally results from the complete loss of filamin A protein, and affects the central nervous system. The clinically separate otopalatodigital disorders (OPD) spectrum disorders are skeletal disorders and were hypothesised to be gain of function phenotype diseases. At the beginning of this work, there was very little structural data available for the human filamins, and none for the crucial highly conserved actin binding domain. This lack of structural data limited the interpretation of the biochemical and genetic data and constrained our understanding of the disease associated mutations that cluster in this domain. These studies aimed to provide insights into the structure and mechanism of actin binding domains, and thus provide a better understanding of the diseases caused when this domain is mutated. A secondary structural analysis and crystal structures of the wildtype and OPD2 associated mutant ABDs were obtained. The overall fold of the three proteins was equivalent as determined by circular dichroism spectroscopy and x-ray crystallography. The ABD from filamin A E254K showed 3.7 fold increased F-actin affinity, accompanied by a reduced thermostability (of 5.6 °C). Western blotting of OPD2, frontometaphyseal dysplasia (FMD) and PVNH patient fibroblast lysates showed similar levels of filamin A compared to the control cells. In addition the OPD and PVNH patient fibroblasts were able to adhere to fibronectin and migrate with an equivalent rate to control cells. Together these results have allowed correlations to be developed between structure, protein stability, actin affinity, cellular phenotype and the overall clinical phenotype. Showing that, at least in one example, OPD2 may be due to an increased actin affinity providing further evidence for a gain of function mechanism of OPD2.
Thomson, Robert Brent. "Cellular mechanisms of acid/base transport in an insect excretory epithelium." Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/31306.
Full textScience, Faculty of
Zoology, Department of
Graduate
Díaz, i. Cirac Anna. "Mechanism of action of cyclic antimicrobial peptides." Doctoral thesis, Universitat de Girona, 2011. http://hdl.handle.net/10803/38252.
Full textAquesta tesi doctoral resulta de la combinació d’estudis mitjançant tècniques experimentals i computacionals amb l’objectiu d’entendre el mecanisme d’acció de "de novo" decapèptids cíclics amb elevada activitat antimicrobiana. Experimentalment, es va avaluar la influència de la substitució dels residus de fenilalanina per triptòfan en la seva activitat antimicrobiana i també la seva estabilitat sèrum humà, per tal de valorar la seva possible aplicació terapèutica envers el càncer. Per altra banda, es va simular la interacció del pèptid BPC194 c(KKLKKFKKLQ), millor candidat de la biblioteca de pèptids cíclics, amb models aniònics de bicapa lipídica. Els resultats van posar en manifest una relació estructura-funció derivada de la conformació estable dels pèptids que participen directament en la permeabilització de la membrana. Es va procedir doncs al disseny racional de nous pèptids cíclics sent el pèptid BPC490 el que va presentar una millor activitat bacteriana en comparació amb el pèptid més actiu de la llibreria original.
Reißmann, Stefanie. "Mechanism of Action of Group II Chaperonins:." Diss., lmu, 2007. http://nbn-resolving.de/urn:nbn:de:bvb:19-73195.
Full textHirschkorn, Martin C. "Dynamic Model of a Piano Action Mechanism." Thesis, University of Waterloo, 2004. http://hdl.handle.net/10012/877.
Full textPlested, Charles Paul. "Mechanism of action of seronegative myasthenia gravis." Thesis, University of Oxford, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.301392.
Full textKeane, Richard. "HPMA copolymer-aminoellipticine conjugates : mechanism of action." Thesis, University College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269617.
Full textBeecroft, Marikka Shannon. "Antimicrobial chelators and their mechanism of action." Thesis, Durham University, 2019. http://etheses.dur.ac.uk/12933/.
Full textChant, Eleanor Laura. "The mechanism of action of ColE1 Rcd." Thesis, University of Cambridge, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.613713.
Full textJackson, Natalie Diane. "The mechanism of action of peroxygen biocides." Thesis, University of York, 1999. http://etheses.whiterose.ac.uk/9825/.
Full textBagnobianchi, A. "The molecular mechanism of action of Bendamustine." Thesis, University College London (University of London), 2015. http://discovery.ucl.ac.uk/1461456/.
Full text